戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 t, similar to FMF patients, retains the full PYRIN domain.
2        Their N termini vary, but most have a pyrin domain.
3 90-amino-acid N-terminal sequence called the PYRIN domain.
4 pha2-alpha3 loop is not a general feature of pyrin domains.
5 two zebrafish caspases containing N-terminal pyrin domains.
6 nod-like receptor family member containing a pyrin domain 3 (NLRP3) inflammasome in a protracted mann
7 diated by the NOD-like receptor containing a pyrin domain 3 (NLRP3) inflammasome, although exactly ho
8  and leucine-rich repeat receptor containing pyrin domain 3 (NLRP3) inflammasome.
9 gomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasomes and induces the rel
10 he absence of Nod-like receptor containing a pyrin domain 3 and absent in melanoma 2.
11 elanoma 2 and Nod-like receptor containing a pyrin domain 3 are partially required for caspase-1 acti
12 otide-binding domain and leucine-rich repeat pyrin domain 3 are simultaneously present in the same in
13 lood leukocytes and encodes a protein with a pyrin domain, a nucleotide-binding site (NBS, NACHT subf
14 BRCA1 (aa 502-802) interacted with the IFI16 Pyrin domain (aa 1-130).
15 sist of three functional domains including a pyrin domain, an NACHT domain, and a leucine-rich repeat
16 amily member that contains an amino-terminal pyrin domain and a carboxy-terminal oligonucleotide/olig
17  N-terminal region that contains a predicted pyrin domain and a putative nuclear localization signal.
18 ein containing a caspase recruitment domain) pyrin domain and the IFI16-double stranded DNA complex h
19  unexpected auto-inhibitory function for the pyrin domain, and provide the first genetic evidence lin
20              Pyrin, a protein of 781 aa with pyrin domain at the N-terminal, negatively regulates inf
21  this response by interacting with the IFI16 pyrin domain, blocking its oligomerization upon DNA sens
22 200 domain of AIM2 binds to DNA, whereas the pyrin domain (but not that of the other PYHIN family mem
23 ing dsDNA, only the Aim2 protein through its pyrin domain can form an inflammasome to activate caspas
24 gomerization domain, leucine rich repeat and pyrin domain containing 1 (NLRP1), NLRP3, and nucleotide
25  these sensors, including NLRP1 (NLR family, pyrin domain containing 1), are described to form an inf
26 ng the NOD-like receptor NLRP10 (NLR family, pyrin domain containing 10); however, the mechanism by w
27 merization domain (NOD)-like receptor family pyrin domain containing 12 (NLRP12) plays a protective r
28            One NLR gene, NLRP12 (NLR family, pyrin domain containing 12)/Monarch-1, has emerged as an
29 ucine-rich repeat containing protein family, pyrin domain containing 3 (NLRP3) (cryopyrin or NALP3) a
30 uble deficiency of Nod like receptor family, pyrin domain containing 3 (NLRP3) and caspase 8 inPstpip
31                  In this context, NLR family pyrin domain containing 3 (NLRP3) inflammasome activatio
32 n and leucine rich repeat containing family, pyrin domain containing 3 (NLRP3) inflammasome as an ess
33 ding domain, leucine-rich-containing family, pyrin domain containing 3 (NLRP3) inflammasome complex a
34  cell sensor leucine-rich-containing family, pyrin domain containing 3 (NLRP3) inflammasome controls
35                                   NLR family pyrin domain containing 3 (NLRP3) inflammasome has been
36 is a key to induce NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome in macrop
37 itin, activate the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome in primed
38       Excessive activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome is involv
39  leucine-rich repeat containing gene family, pyrin domain containing 3 (NLRP3) inflammasome to induce
40                The NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome, a multip
41 oligomerization domain-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome-dependent
42  of Tat in priming and activating NLR family pyrin domain containing 3 (NLRP3) inflammasomes in micro
43 ammasome system, mediated by the NLR family, pyrin domain containing 3 (NLRP3) initiating protein, wa
44 leotide-binding domain, leucine-rich repeat, pyrin domain containing 3 (NLRP3) is a key component of
45                    NOD-like receptor family, pyrin domain containing 3 (NLRP3) protein is a key compo
46 rm depended on the NOD-like receptor family, pyrin domain containing 3 (NLRP3) sensor and the apoptos
47  components of the NOD-like receptor family, pyrin domain containing 3 (NLRP3), and absent in melanom
48 n and leucine rich repeat containing family, pyrin domain containing 3 (NLRP3).
49  Activation of the NOD-like receptor family, pyrin domain containing 3 (NLRP3)/caspase-1 inflammasome
50 gomerization domain, leucine-rich repeat and pyrin domain containing 3 (NRLP3) inflammasome members (
51 erization domain (NOD)-like receptor family, pyrin domain containing 3 activation in the inflammasome
52 tightly regulating NOD-like receptor family, pyrin domain containing 3 activation.
53 rich repeat-containing-like receptor family, pyrin domain containing 3 and autophagosome-associated m
54 rvention targeting NOD-like receptor family, pyrin domain containing 3 inflammasome activity induces
55 he key role of the NOD-like receptor family, pyrin domain containing 3 inflammasome during acute pneu
56 n regulate hepatic steatosis; the NLR family pyrin domain containing 3 inflammasome is critically inv
57 he activity of the NOD-like receptor family, pyrin domain containing 3 inflammasome when compared wit
58 ypoxia activate the NOD-like receptor family pyrin domain containing 3 inflammasome.
59  IL-1beta-producing NOD-like receptor family pyrin domain containing 3 inflammasome.
60 otide-binding domain and leucine-rich repeat pyrin domain containing 3 inflammasome.
61  innate immune-sensing complex known as "NLR-Pyrin domain containing 3" (NLRP3) inflammasome, also kn
62 omain leucine-rich repeat containing family, pyrin domain containing 3) inflammasome complex, assembl
63         The NLRP3 (NOD-like receptor family, pyrin domain containing 3) inflammasome is a multiprotei
64 flammasomes, and that the NLRP3 (NLR family, pyrin domain containing 3) inflammasome is not involved
65 OD2 target, NLRP3 (NOD-like receptor family, pyrin domain containing 3) is of importance in the patho
66 e-recruitment domain) and NLRP3 (NLR family, pyrin domain containing 3), which are essential for casp
67 spase-1, and NLRP3 (NOD-Like Receptor family Pyrin domain containing 3).
68 eased expression of inflammatory (NLR family pyrin domain containing 3, interleukins 1beta and 6, and
69 rich repeat-containing-like receptor family, pyrin domain containing 3-associated inflammasomes and i
70 e-1/Caspase-4- and NOD-like receptor family, pyrin domain containing 3-dependent inflammatory cell de
71 ce deficient in the NOD-like receptor family pyrin domain containing 6 (NLRP6) inflammasome feature e
72 g oligomerization domain (NOD)-like receptor pyrin domain containing family of gene 12 (Nlrp12) are a
73  salivary levels of nod-like receptor family pyrin domain containing protein (NLRP) 3, apoptosis-asso
74 tide-binding domain, leucine-rich repeat and pyrin domain containing protein (NLRP) family, which for
75 leotide-binding domain, leucine-rich repeat, pyrin domain containing protein 3 (NLRP3) inflammasome.
76 te the NLRP3 (Nacht, leucine-rich repeat and pyrin domain containing protein 3) inflammasome.
77 (ATG5), ATG7 and ATG16L1 but not NLR family, pyrin domain containing-3 (NALP3).We show that NOD2-medi
78 tly demonstrated that the NOD-like receptor, pyrin domain containing-3 (NLRP3) contributes to renal i
79 nding domain leucine-rich repeat containing, Pyrin domain containing-3 and for absent in melanoma 2 i
80 nding domain leucine-rich repeat containing, Pyrin domain containing-3 inflammasome, and caspase-4 ph
81 ting a role for the NOD-like receptor family pyrin domain containing-3 inflammasome.
82 e nucleotide oligomerization domain receptor pyrin-domain containing protein 3 (NLRP3) by Salmonella
83                           NLRP1 (NLR family, pyrin domain-containing 1) is a contributor to innate im
84 me components, we found that both NLR family pyrin domain-containing 3 (Nlrp3) and apoptosis-associat
85 -1beta dependent on NOD-like receptor family pyrin domain-containing 3 (NLRP3) and ASC due to the sec
86 mutations in NOD-like receptor (NLR) family, pyrin domain-containing 3 (NLRP3) cause neonatal-onset m
87 oligomerization domain-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome and conco
88 main, leucine-rich repeat-containing family, pyrin domain-containing 3 (NLRP3) inflammasome as well a
89 oligomerization domain-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome drives ma
90                               The NLR family pyrin domain-containing 3 (NLRP3) inflammasome has been
91                The NOD-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome is a casp
92 omain-like receptor, leucine-rich repeat and pyrin domain-containing 3 (NLRP3) inflammasome is now no
93 g oligomerization domain-like receptor (NLR) pyrin domain-containing 3 (Nlrp3) inflammasome is though
94 leucine-rich repeat containing family (NLR), pyrin domain-containing 3 (NLRP3) inflammasome plays a k
95 cleotide-binding domain, leucine-rich repeat pyrin domain-containing 3 (NLRP3) inflammasome.
96  oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome.
97     In this study, we showed that NLR family pyrin domain-containing 3 (Nlrp3) is required to induce
98 n (ASC) inflammasomes, including NLR family, pyrin domain-containing 3 (NLRP3), but not NLR family, c
99 ts, including NOD-like receptor (NLR) family pyrin domain-containing 3 (NLRP3), NLRP1, NLR family CAR
100 ng and oligomerization, leucine-rich repeat, pyrin domain-containing 3 (NLRP3), simultaneously and di
101 otide-binding oligomerization domain family, pyrin domain-containing 3 inflammasome activation upon H
102 is detected by the NOD-like receptor family, pyrin domain-containing 3 inflammasome and can trigger a
103  and activates the NOD-like receptor family, pyrin domain-containing 3 inflammasome.
104 oligomerization domain-like receptor family, pyrin domain-containing 3 inflammasome.
105 main, leucine-rich-repeat-containing family, pyrin domain-containing 3) inflammasome mediates product
106 cleotide-binding domain, leucine-rich repeat/pyrin domain-containing 3.
107 cruitment domain-containing 4 or NLR family, pyrin domain-containing 6, are required for triggering t
108 rodent NLRP1B (NACHT leucine-rich repeat and pyrin domain-containing protein 1B).
109 erization domain (NOD)-like receptor family, pyrin domain-containing protein 3 (Nlrp3) expression was
110          The NOD-like receptor (NLR) family, pyrin domain-containing protein 3 (NLRP3) inflammasome i
111                          The NACHT, LRR, and pyrin domain-containing protein 3 (NLRP3) inflammasome i
112 osolic contact, and activation of NLR family pyrin domain-containing protein 3 (NLRP3) inflammasomes
113 binding oligomerization domain-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasomes
114 inding oligomerization-like receptor family, pyrin domain-containing protein 3) activation, either by
115 flammasome components Nalp3 (NACHT, LRR, and pyrin domain-containing protein 3), ASC (apoptosis-assoc
116   The SREBP-induced NOD-like receptor family pyrin domain-containing protein inflammasome and its ins
117 e activation of the NOD-like receptor family pyrin domain-containing protein inflammasome in macropha
118              The myxoma virus (MYXV)-encoded pyrin domain-containing protein M013 coregulates inflamm
119 t nucleotide-binding leucine-rich repeat and pyrin domain-containing receptor 12 (NLRP12) impedes alt
120 ding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) inflammasome controls
121 ding domain, leucine-rich-containing family, pyrin domain-containing-3 (Nlrp3, but also known as Nalp
122 ucine-rich-repeat-containing receptor (NLR), pyrin-domain-containing 3 (NLRP3) inflammasome in human
123 merization drug AP20187, suggesting that the PYRIN domain functions as an oligomerization domain, whe
124 gy include the elucidation of the N-terminal PYRIN domain in protein-protein interactions, the descri
125 8), and Glu(16), believed critical for Pyrin/Pyrin domain interaction, are important for inflammasome
126 LP1, is unlikely to be a common attribute of pyrin domain interactions.
127                                          The PYRIN domain is a recently identified protein-protein in
128                        We show here that the pyrin domain of AIM2 (AIM2(PYD)) drives both filament fo
129                            VHHASC leaves the Pyrin domain of ASC functional and stabilizes a filament
130  on the recent near-atomic structures of the PYRIN domain of ASC in the protein filament of inflammas
131                          Substitution of the PYRIN domain of ASC with an inducible FKBP12 oligomeriza
132 and leucine-rich repeat regions, but not the pyrin domain of CIAS1, are responsible for this inhibiti
133 weak affinity, and it is the non-DNA-binding pyrin domain of IFI16 that drives the cooperative filame
134 the structure and dynamics of the N-terminal pyrin domain of NLRP12 (NLRP12 PYD) determined using NMR
135 the structure and dynamics of the N-terminal pyrin domain of NLRP7 (NLRP7 PYD) obtained by NMR spectr
136  protein that interacts selectively with the PYRIN domain of PYPAF1.
137                                          The pyrin domains of both Caspy and zAsc were required for t
138 ty, de Almeida et al. (2015) report that the PYRIN domain-only protein (POP1) efficiently inhibits in
139 cent developments in elucidating the role of PYRIN domain-only proteins (POPs) and the related CARD-o
140                                              Pyrin domain-only proteins (POPs) are recently evolved,
141                         Mutations in another PYRIN domain protein, termed cryopyrin, are responsible
142              It is composed of an N-terminal pyrin domain (PYD) and a C-terminal caspase recruitment
143 omain structure, consisting of an N-terminal pyrin domain (PYD) and a C-terminal caspase-recruitment
144 e to intramolecular interactions between its pyrin domain (PYD) and B-box.
145 hich consists of two domains, the N-terminal pyrin domain (PYD) and the C-terminal CARD.
146 izing double-stranded DNA and its N-terminal pyrin domain (PYD) for eliciting downstream effects thro
147 ary inflammasome complexes, achieved through pyrin domain (PYD) interactions between sensors and ASC
148 otein ASC and initiate polymerization of its pyrin domain (PYD) into filaments.
149 on dsDNA engagement, the AIM2 amino-terminal pyrin domain (PYD) is responsible for downstream signali
150 rk of highly intercrossed filaments, whereas pyrin domain (PYD) or caspase activation and recruitment
151                                              Pyrin domain (PYD) proteins have recently emerged as imp
152                                         Many pyrin domain (PYD) proteins modulate NF-kappaB activity
153 recruitment domain (CARD) subfamily, and the pyrin domain (PYD) subfamily is one of the largest domai
154 ng studies on human growth hormone (hGH) and pyrin domain (PYD), and the results show how mutations a
155 uman NLRP1, mouse NLRP1b lacks an N-terminal pyrin domain (PYD), indicating that the assembly of the
156           Inflammasome assembly requires the PYRIN domain (PYD)-containing adaptor ASC, and depends o
157                                              Pyrin domain (PYD)-containing proteins are key component
158                       Here we identified the PYRIN domain (PYD)-only protein POP3, which competes wit
159 tion is controlled by phosphorylation of its pyrin domain (PYD).
160 RD (caspase activation and recruitment), and pyrin domains (PyD).
161 or domains, caspase recruitment domains, and pyrin domains (PYD).
162         Inflammasome assembly is mediated by pyrin domains (PYDs) and caspase recruitment domains, wh
163 ntain caspase recruitment domains (CARDs) or pyrin domains (PYDs).
164 ns of caspase recruitment domains (CARDs) or PYRIN domains (PYDs).
165 , which harbor essential N-terminal CARD and PYRIN domains, respectively.
166        MNDA and related proteins contain the pyrin domain that functions in signaling associated with
167                  The surface residues on the pyrin domain that mediate the cooperative DNA binding ar
168 -like protein containing a CARD) through its pyrin domain to activate caspase-1.
169    We also show here that PAN1 binds via its PYRIN domain to ASC, an adapter protein involved in casp
170                                          The pyrin domain was identified recently in multiple protein
171 ull-length ASC, but not its isolated CARD or PYRIN domain, with procaspase-1 induced activation of pr

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top